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Abstract
Despite many advances in prevention and perioperative 
care, deep sternal wound infection (DSWI) remains a 
pressing concern in cardiac surgery, with a still relevant 
incidence and with a considerable impact on in-hospital 
mortality and also on mid- and long-term survival. The 
permanent high impact of this complication is partially 
related to the increasing proportion of patients at high-
risk for infection, as well as to the many patient and 
surgical risk factors involved in the pathogenesis of 
DSWI. The prophylactic antibiotic therapy is one of 
the most important tools in the prevention of DSWI. 
However, the choice of antibiotic, the dose, the duration, 
the adequate levels in serum and tissue, and the timing 
of antimicrobial prophylaxis are still controversial. The 
treatment of DSWI ranges from surgical revision with 
primary closure to surgical revision with open dressings 
or closed irrigation, from reconstruction with soft tissue 
flaps to negative pressure wound therapy (NPWT). 
However, to date, there have been no accepted recom-
mendations regarding the best management of DSWI. 
Emerging evidence in the literature has validated the 
efficacy and safety of NPWT either as a single-line 
therapy, or as a “bridge” prior to final surgical closure. 
In conclusion, the careful control of patient and surgical 
risk factors - when possible, the proper antimicrobial 
prophylaxis, and the choice of validated techniques of 
treatment could contribute to keep DSWIs at a minimal 
rate.
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Core tip: Intensivists and cardiothoracic surgeons are 
commonly worried about surgical site infections due 
to increasing length of stay, costs, and mortality. In 
particular, deep sternal wound infection (DSWI) is a 
worrying complication after cardiac surgery, with a still 
relevant incidence. Unfortunately, DWSI appearance 
is related to a wide number of both patient and 
surgical factors. This review may be useful for guiding 
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physicians to the knowledge of main risk factors and 
the choice of the appropriate management of DWSIs 
with the aim of reducing the rate of this potentially 
devastating complication in cardiac surgery patients.
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INTRODUCTION
Deep sternal wound infection (DSWI) is one of the 
most complex and potentially devastating complications 
following median sternotomy in cardiac surgery with a 
significant impact on both patient prognosis and hospital 
budgets[1-5]. Despite many advances in prevention, it 
still remains significant and ranges between 0.5% and 
6.8%[6-10], with in-hospital mortality rates between 
7% and 35%[2,3,7,9,11-13]. Moreover, mid- and long-term 
survival is significantly reduced in patients that have 
experienced DSWI. By the end of the first year, Filsoufi 
et al[6] found a 15% absolute survival difference between 
patients without DSWI and those who had developed this 
complication. In a 10-year follow-up study after coronary 
artery bypass grafting, the adjusted survival rate was 
39% for patients who developed DSWI compared with 
70% in patients who did not[14]. Excess costs arise 
primarily owing to additional antibiotic treatments and 
surgical procedures, as well as increased hospital length 
of stay[13,15].
The management of DSWI has progressed through 
long-lasting clinical experience. Commonly adopted 
strategies of treatment include surgical revision with 
primary closure, surgical revision with open dressings 
or closed irrigation, reconstruction with soft tissue flaps, 
and application of negative pressure wound therapy 
(NPWT)[16-18]. However, at the moment, there has 
been no general consensus regarding the appropriate 
management of DSWI.
DEFINITION
According to Centers for Disease Control and Prevention 
(CDC) guidelines, the definition of a DSWI requires 
positive culture results of surgical sites or drainage from 
the mediastinal area or evidence of infection during 
surgical re-exploration or fever, sternal instability, and 
positive blood culture results[19].
RISK FACTORS
Patient and surgical factors contribute to the risk of 
DSWI after cardiothoracic surgery. Patient factors include 
age[20-22], female sex[20,22,23], obesity[2,4,20,21,24-28], diabetes 
mellitus or hyperglycemia during the perioperative 
period[2,20,21,24,26-29], smoking tobacco[2,4,28-30], recent treat-
ment with antibiotics[31], Staphylococcus aureus nasal 
carriage[32,33], skin infection anywhere on the body[31], 
chronic obstructive pulmonary disease[25,27], heart 
failure[2,34], kidney dysfunction[27,34], peripheral vascular 
disease[2,26], and emergent or urgent surgery[28,35].
The reason for the increased risk of DSWI in obese 
patients can be related to the poor perfusion of sub-
cutaneous adipose layers with low levels of prophylactic 
antibiotics in this tissue. Gummert et al[24] found a 
1.5-times increased adjusted risk of DSWI after cardiac 
surgery in patients with body mass index > 30 kg/m2. 
Filsoufi et al[6] reported that obesity was associated with 
a more than 2-fold increased risk of DSWI.
Convincing evidence has emerged that the control 
of blood glucose levels during surgery and the imme-
diate postoperative period with frequent monitoring 
and protocols for continuous intravenous administration 
insulin can decrease DSWI rate[36,37]. Researchers at the 
Mayo Clinic concluded that a 20 mg/dL (1.11 mmol/L) 
increase in the mean intraoperative blood glucose level 
correlated with an increase of more than 30% in adverse 
outcomes[38]. A large prospective study of diabetic 
patients undergoing cardiac surgery demonstrated that 
hyperglycemia was an independent risk factor for death, 
length of hospital stay, and infection rates, and found 
that a continuous insulin infusion reduced these risks[39].
Smoking tobacco can impair the tissue micro-
circulation and increase the risk of DSWI. Møller et al[40] 
showed that preoperative cessation of smoking 6-8 wk 
prior to operation significantly reduced the infection 
rate in a prospective randomized trial in orthopedic 
prosthesis surgery. Actually, the CDC guidelines re-
commend smoking cessation at least 30 d prior to 
surgery[19].
The patient’s carriage of Staphylococcus aureus 
on skin and nares has been identified as an important 
risk factor for DSWI[32,33]. The Society of Thoracic 
Surgeons practice guidelines upon antimicrobial pro-
phylaxis recommend routine 5-d mupirocin 2% nasal 
administration for all patients undergoing cardiac surgery 
in the absence of a documented negative testing for 
staphylococcal colonization[41]. However, concerns still 
remain about the extensive use of mupirocin because of 
lack of efficacy, risk of widespread high-level resistance, 
and costs[42-44]. A systematic review of the literature 
and meta-analysis by Kallen et al[45] demonstrated a 
45% reduction in surgical site infections (SSIs) caused 
by Staphylococcus aureus with the use of preoperative 
mupirocin among cardiac surgery patients known to 
be colonized with Staphylococcus aureus. Of note, the 
only prospective, randomized, and double-blinded trial 
of mupirocin in cardiac surgery patients did not show 
benefit: No patients with poststernotomy mediastinitis 
caused by methicillin-resistant Staphylococcus aureus 
(MRSA) had identical isolates in preoperative and 
surgical-site cultures[46].
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Surgical risk factors include prolonged duration of 
aortic cross clamp, cardiopulmonary bypass perfusion 
or overall surgery[22,26], use of internal mammary artery 
(IMA) grafts-especially bilaterally-[2,24,25,27,30], inadvertent 
paramedian sternotomy[47], use of bone wax, extensive 
use of electrocauterization[27], surgical procedures 
requiring prosthesis implant, use of intra-aortic balloon 
pump or ventricular assist device[23,27], postoperative 
bleeding[10], blood transfusions, re-exploration for 
bleeding[6,23,24,48,49], re-operation, postoperative res-
piratory failure with prolonged mechanical ventilation[2,6], 
and prolonged stay in intensive care unit (ICU)[4,24,26].
Controversial opinions still remain on the IMA harvest 
technique. The skeletonization harvest technique is 
already known to severely reduce the incidence of DSWI 
- particularly in diabetic and obese patients - because 
of the better preservation of collateral sternal blood 
flow and internal thoracic veins[50]. However, many 
cardiothoracic surgeons are reluctant to application 
this technique as it can easily lead to graft conduit 
damage[51]. Evidences also suggest the need for dosing 
adjustment following IMA harvesting as this significantly 
diminishes antibiotic penetration into the presternal 
tissue[52].
Level of concern has varied regarding to the risk of 
DSWI due to use of bone wax. Animal studies showed 
an increased risk of Staphylococcus aureus infections[53]; 
however, a prospective, randomized trial of 400 patients 
found no detrimental effects[54].
Finally, adherence to basic principles of care con-
tributes to reduce the risk of DSWI. These mainly 
include reduced preoperative hospital stay, increased 
perioperative oxygenation, preoperative showering using 
antiseptic solution, hair removal over the operating site 
using scissors or a depilatory cream instead of shaving, 
and scrubbing of the operation site with a proper 
antiseptic solution and letting it dry[6,19,31,55]. Chlorh-
exidine-, alcohol- or povidone-iodine-based solutions can 
be used; indeed, the CDC guidelines do not recommend 
one antiseptic solution over the others[19].
PATHOGENS
Recent reports focused on a growing number of 
DSWIs caused by methicillin-resistant Gram-positive 
pathogens[56]. Staphylococcus epidermidis is one of the 
most common agents in poststernotomy mediastinitis 
when foreign materials such as prosthetic heart valve 
are implanted; moreover, approximately 75% of the 
Staphylococcus epidermidis strains are methicillin-
resistant[57]. The other major pathogen in poststernotomy 
mediastinitis is Staphylococcus aureus. The latter 
microorganism has been increasingly associated with 
colonization of the patients’ nares. National Nosocomial 
Infections Surveillance System reports that the rate of 
MRSA has risen from 30% in 1989 to 60% in 2005 in 
ICU patients with nosocomial infections and MRSA was 
the causative microorganism in a third of the patients 
with DSWI[58].
ANTIMICROBIAL PROPHYLAXIS
The advantages of proper antimicrobial prophylaxis in 
patients undergoing cardiac surgery have been clearly 
demonstrated[19,59,60]. However, the choice of antibiotic, 
the dose, the duration, the adequate levels in serum 
and tissue, and the timing of antimicrobial prophylaxis 
are still controversial[11,41,61].
The Society of Thoracic Surgeons Practice Guidelines 
on antimicrobial prophylaxis in cardiac surgery recom-
mended that a cephalosporin should be given within 60 
min from the skin incision and be continued for 24-72 
h[41,61]. First generation (cefazolin), second generation 
(cefamandole and cefuroxime), and third generation 
(cefotaxime) cephalosporins have been shown to be 
effective in reducing SSIs in cardiac surgery; however, 
the superiority of one class over another has not been 
proven[62-64].
The frequent identification of MRSA as the cause 
of DSWI has brought the attention on vancomycin as 
the prophylactic drug of choice[10]. Engelman et al[41] 
stated that vancomycin is reserved mainly for patients 
with a history of type Ⅰ allergic reaction to β-lactam 
agents or in the setting of the institutional presence of a 
“high incidence” of MRSA (class ⅡB recommendation, 
level of evidence C). Vancomycin should be given with 
any of the following doses: 1000 mg, 1500 mg, or 15 
mg/kg over 1 h, with completion within 1 h of the skin 
incision[41]. The reason for the 1-h infusion is related to 
the risk of histamine-release phenomenon characterized 
by extensive erythematous rash that involves the upper 
chest and face (“red man syndrome”) that can be 
triggered by a rapid infusion of vancomycin[41,61]. More-
over, studies in the literature showed that the incidence 
of infection is decreased when the preoperative dose 
is administered within 1 h before surgical incision[11,65]. 
Regarding the duration, postoperative prophylactic 
antibiotics are given for 48 h or less (class ⅡA recom-
mendation, level of evidence B)[61].
A meta-analysis comparing cephalosporins with 
glycopeptides as antimicrobial prophylaxis regimens 
found a higher frequency of postoperative SSIs and a 
trend toward an increased risk of Gram-positive SSI in 
the glycopeptide group but a lower frequency of SSIs 
caused by resistant gram-positive pathogens[66].
The relationship between timing of prophylactic 
antimicrobial administration and risk of infection is an 
additional field of debate. The 2011 American College 
of Cardiology/American Heart Association guidelines for 
cardiac surgery recommend that “Antibiotic prophylaxis 
should be initiated 30 to 60 min before surgery”[9]. 
Key studies have demonstrated that antimicrobial 
prophylaxis administered too late or too early reduces 
the efficacy of the antimicrobial prophylaxis and 
increases the risk of infection[10,11,65,67]; conversely, other 
reports do not clearly demonstrated the superiority of 
the 1-h window[68-70].
Ideally, short courses of antimicrobial prophylaxis 
are preferred over longer courses to reduce costs, drug 
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additional surgical trauma and late flap-related morbidity 
such as muscular weakness, pain, and hernias[86]. 
An alternative plastic procedure to pectoralis muscle 
flaps is the use of omentum that promotes significant 
angiogenesis, immunologic function, and antimicrobial 
activity supporting tissue-generation promotion with great 
capacity to occupy dead space[6,87,88]. Usually, the use of 
omentum is considered in the case of complex wounds 
or when the defect is extremely wide with significant 
sternal loss. Specifically, a definite preference has been 
expressed for the use of omentum when the primary 
causative pathogen is particularly resistant, such as 
MRSA[80,89] and Candida[90] or when the patients suffering 
from diabetes mellitus[91].
However, complications occurred in up to 18% of 
patients treated with this approach[16,92].
Several recent studies, meta-analyses, and syste-
matic reviews have validated the efficacy of NPWT in 
DSWI either as a single-line therapy, or as a “bridge” 
prior to final surgical closure[93-97]. This wound-healing 
technique is based on the application of continuous 
or intermittent negative pressure to a wound, which 
results in arteriolar dilatation and, subsequently, deter-
mines wound perfusion and granulation tissue prolifera-
tion[57,85,93]. In vitro and clinical studies designed to 
determine the effect of NPWT lent convincing evidence 
of efficacy and safety in term of decrease of edema, 
exudation, and microbial colonization as well as reduction 
of inflammatory cytokine release[57,85,98-100].
In case of diagnosis of DSWI, an early application 
of NPWT was associated to a faster healing and an 
increased likelihood of survival[18,97,101,102]. Moreover, 
several studies demonstrated shorter treatment duration 
and length of hospital stay, as well as lower costs in 
patients treated with NPWT[96,98,100,103]. NPWT was also 
successfully applied in the case of MRSA mediastinitis 
and as a temporizing treatment prior to secondary 
closure in mediastinitis due to Candida[90,104,105].
Conversely, other authors suggested that prolonged 
application of NPWT can result in chronic infection due 
to a shift in bacterial species and to an increased growth 
of some of them, such as Staphylococcus aureus[99,106]. 
Different studies have focused on factors that can 
predict failure of NPWT. Gdalevitch et al[107] found that 
positive blood cultures, wound depth of ≥ 4 cm, and 
high degree of bony exposure and sternal instability are 
significant predictors of NPWT failure. Pericleous et al[108] 
highlighted also the importance of lung emphysema, 
corticosteroids, and advanced age. Finally, Gustafsson et 
al[109] stressed bacteremia or elevated plasma C-reactive 
protein levels as the most sensitive predictors of failure.
The positive effects of NPWT on complicated surgical 
wounds have triggered the interest in using NPWT also 
after closure of clean and sutured wounds to prevent 
SSIs in patients at high risk of developing DSWI[110]. 
The surgical incision management system (Prevena™ 
Incision Management System, Kinetic Concepts Inc., San 
Antonio, TX, United States) consists of a single-use NPWT 
that delivers negative pressure of 75-125 mmHg (10-16.7 
toxicity, infection with Clostridium difficile, and the 
appearance of resistant pathogens[11,19,61,65,71]. However, 
the use of cardiopulmonary bypass, the hypothermia, 
the length of operation, the high mortality and costs 
of DSWI suggest to prolonging the antimicrobial pro-
phylaxis in cardiac surgery. A 2011 systematic review 
and meta-analysis of the literature significantly favored 
longer-term antimicrobial prophylaxis of more than 24 h 
in these patients[72]. Similarly, Lador et al[73] showed that 
shorter duration of prophylaxis (≤ 24 h) was associated 
with a higher rate of DSWI, surgical intervention for any 
kind of SSI, and endocarditis; whereas, no difference 
between 48 h vs longer durations was found for all 
outcomes.
There is absolutely no data for continuing anti-
microbial prophylaxis until chest drains are removed[61]. 
Some studies highlighted the importance of weight-
based antibiotic dosing in obese patients and the 
need for repeated doses during prolonged procedures 
(more than two half-lives of the drug) or in case of 
excessive blood loss during the procedure[11,74]. Other 
investigators reported that a cefazolin bolus followed 
by continuous infusion improved pharmacokinetic and 
pharmacodynamic values, including concentrations in 
the cardiac muscle[75].
MANAGEMENT
Debridement with primary closure has been the treat-
ment of choice for a long time and, until now, it can be 
considered for infection localized to a small part of the 
sternum with little or no purulent drainage. Debridement 
is usually associated with the advancement of the 
pectoralis muscles and can be done in a single phase 
procedure or in a delayed closure with multiple open 
dressing changes followed by sternal re-wiring[17,76-78]. The 
latter treatment allows improved accuracy in assessing 
the extent of the sternal infection and reduces the risk of 
recurrent infection but carries on major disadvantages: 
Thoracic instability, prolonged immobilization, and 
mechanical ventilation with increased risk of complications 
such as thrombosis, muscular weakness, and pneum-
onia[17,76-79]. Concerns still remain about the need for 
obtaining negative cultures at the time of closure. Two 
recent studies found that the presence of positive tissue 
cultures did not affect the rate of recurrent infections[80,81].
An important step forward in the treatment of DSWI 
occurred with the introduction of continuous irrigation 
using closed chest catheter following revision. Further 
developments were achieved with antibiotic irrigation 
but several studies have reported high rates of failure 
and mortality[82-84].
The unsatisfactory results of these different app-
roaches increased interest in plastic procedures as 
alternative treatments[6,79,84]. Bilateral pectoralis muscle 
flaps, as either advancement or turnover flaps, are the 
most usual plastic procedures in the dealing of DSWI[16,85]. 
This surgical management has a quite low mortality 
rate but carries a series of disadvantages, including 
Cotogni P et al . Wound infections in cardiac surgery
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KPa); this system holds the incision edges together, 
reduces lateral tension and edema, stimulates perfusion, 
and protects the surgical site from external infectious 
sources[110]. Grauhan et al[111] showed significant reduc-
tion of SSIs in obese patients (body mass index > 30 
kg/m2) with median sternotomy compared with patients 
treated with standard wound dressings. In general, 
retrospective studies and randomized controlled trials 
provided a substantial body of evidence that the use of 
this prophylactic wound dressing technique may reduce 
the incidence of wound infections[112-114].
CONCLUSION
Despite several progresses in prevention and perioperative 
care, DSWI is still a permanent concern in cardiac surgery 
because of its significant rate and relevant impact on 
length of hospital stay, costs, and mortality. The incidence 
of this complication is in part due to the increased number 
of patients at high-risk for infection because of advanced 
age and rate of relevant comorbidities in the population 
undergoing cardiac surgery. A rigorous attention to the 
details of preoperative, intraoperative, and postopera-
tive management could contribute to keep DSWIs at a 
minimal rate.
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